Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin M Posadas

Showing results (1-10 of 112) with videos related to

Pageof 12
Sort By:
Anti-Cancer Agents in Medicinal Chemistry|November 21, 2009
Kinase inhibitors in prostate cancerSuwicha Limvorasak, Edwin M Posadas
Expert Opinion on Pharmacotherapy|December 4, 2009
Pazopanib: therapeutic developmentsSuwicha Limvorasak, Edwin M Posadas
JNCI Cancer Spectrum|July 25, 2022
Intensification of Androgen Deprivation Therapy in High-Risk, Nonmetastatic Prostate Cancer: Lessons From STAMPEDEJun Gong, Edwin M Posadas
Oncology (Williston Park, N.Y.)|May 2, 2012
Systemic therapy in renal cell carcinoma: advancing paradigmsEdwin M Posadas, Robert A Figlin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2012
Understanding the role of MET kinase in cancer therapyEdwin M Posadas, Robert A Figlin
Nature Reviews. Urology|April 23, 2014
Kidney cancer: progress and controversies in neoadjuvant therapyEdwin M Posadas, Robert A Figlin
Clinical Prostate Cancer|March 30, 2004
Approaches to inhibit invasiveness and metastasis in prostate cancerEdwin M Posadas, William L Dahut
Urology|January 4, 2011
Editorial commentPeter H O'Donnell, Edwin M Posadas
Journal of Oncology Practice|May 13, 2016
Personalized Therapeutics and Value in Renal Cell Carcinoma: Moving Beyond Lines of TherapyEdwin M Posadas, Robert A Figlin
American Journal of Therapeutics|January 6, 2004
The emerging role of bisphosphonates in prostate cancerEdwin M Posadas, William L Dahut, James Gulley
Pageof 12

Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
Anti-Cancer Agents in Medicinal Chemistry|November 21, 2009
Kinase inhibitors in prostate cancerSuwicha Limvorasak, Edwin M Posadas
Expert Opinion on Pharmacotherapy|December 4, 2009
Pazopanib: therapeutic developmentsSuwicha Limvorasak, Edwin M Posadas
JNCI Cancer Spectrum|July 25, 2022
Intensification of Androgen Deprivation Therapy in High-Risk, Nonmetastatic Prostate Cancer: Lessons From STAMPEDEJun Gong, Edwin M Posadas
Oncology (Williston Park, N.Y.)|May 2, 2012
Systemic therapy in renal cell carcinoma: advancing paradigmsEdwin M Posadas, Robert A Figlin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2012
Understanding the role of MET kinase in cancer therapyEdwin M Posadas, Robert A Figlin
Nature Reviews. Urology|April 23, 2014
Kidney cancer: progress and controversies in neoadjuvant therapyEdwin M Posadas, Robert A Figlin
Clinical Prostate Cancer|March 30, 2004
Approaches to inhibit invasiveness and metastasis in prostate cancerEdwin M Posadas, William L Dahut
Urology|January 4, 2011
Editorial commentPeter H O'Donnell, Edwin M Posadas
Journal of Oncology Practice|May 13, 2016
Personalized Therapeutics and Value in Renal Cell Carcinoma: Moving Beyond Lines of TherapyEdwin M Posadas, Robert A Figlin
American Journal of Therapeutics|January 6, 2004
The emerging role of bisphosphonates in prostate cancerEdwin M Posadas, William L Dahut, James Gulley
Pageof 12